Journal of Applied Physiology, Vol 61, Issue 6 2210-2217, Copyright © 1986 by American Physiological Society

ARTICLES

Platelet-activating factor increases lung vascular permeability to protein

K. E. Burhop, J. G. Garcia, W. M. Selig, S. K. Lo, H. van der Zee, J. E. Kaplan and A. B. Malik

We studied the effects of platelet-activating factor (PAF) on pulmonary hemodynamics and microvascular permeability in unanesthetized sheep prepared with lung-lymph fistulas. Since cyclooxygenase metabolites have been implicated in mediating these responses, we also examined the role of the cyclooxygenase pathway. PAF infusion (4 micrograms X kg-1 X h-1 for 3 h) produced a rapid, transient rise in pulmonary arterial pressure (Ppa), pulmonary vascular resistance (PVR), plasma thromboxane B2 concentration (TxB2), and pulmonary lymph flow (Qlym). The lymph-to-plasma protein concentration ratio (L/P) did not change from base line. Pretreatment with the cyclooxygenase inhibitor, sodium meclofenamate, prevented the generation of TxB2 and the hemodynamic changes but did not prevent the increase in Qlym. The estimated protein reflection coefficient decreased from a control value of 0.66 +/- 0.04 to 0.43 +/- 0.06 after PAF infusion. We also studied the effects of PAF on endothelial permeability in vitro by measuring the flux of 125I-albumin across cultured bovine pulmonary artery endothelial cells (EC) grown to confluency on a gelatinized micropore filter and mounted within a modified Boyden chemotaxis chamber. PAF (10(-8) to 10(-4) M) had no direct effect on EC albumin permeability, suggesting that the increase in permeability in sheep was not the direct lytic effect of PAF. In conclusion, PAF produces pulmonary vasoconstriction mediated by cyclooxygenase metabolites. PAF also increases pulmonary vascular permeability to protein that is independent of cyclooxygenase products and is not the result of a direct effect of PAF on the endothelium.

This article has been cited by other articles:

				J. Y. C. Tsang, W. J. E. Lamm, I. R. Starr, and M. P. Hlastala Spatial pattern of ventilation-perfusion mismatch following acute pulmonary thromboembolism in pigs J Appl Physiol, May 1, 2005; 98(5): 1862 - 1868. [Abstract] [Full Text] [PDF]

				G. Montrucchio, G. Alloatti, and G. Camussi Role of Platelet-Activating Factor in Cardiovascular Pathophysiology Physiol Rev, October 1, 2000; 80(4): 1669 - 1699. [Abstract] [Full Text] [PDF]

				J. D. Kim, C. J. Baker, R. F. Roberts, S. H. Darbinian, K. A. Marcus, S. M. Quardt, V. A. Starnes, and M. L. Barr Platelet activating factor acetylhydrolase decreases lung reperfusion injury Ann. Thorac. Surg., August 1, 2000; 70(2): 423 - 428. [Abstract] [Full Text] [PDF]

				S. G. Greenberg and K. E. Clark Hemodynamic effects of platelet-activating factor in nonpregnant and pregnant sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R996 - R1001. [Abstract] [Full Text] [PDF]

				J. M. Miotla, P. K. Jeffery, and P. G. Hellewell Platelet-activating Factor Plays a Pivotal Role in the Induction of Experimental Lung Injury Am. J. Respir. Cell Mol. Biol., February 1, 1998; 18(2): 197 - 204. [Abstract] [Full Text]